A Cell-Penetrating Peptide Modified Cu<sub>2−x</sub>Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy

Radiotherapy (RT) is one of the main clinical therapeutic strategies against cancer. Currently, multiple radiosensitizers aimed at enhancing X-ray absorption in cancer tissues have been developed, while limitations still exist for their further applications, such as poor cellular uptake, hypoxia-ind...

Full description

Bibliographic Details
Main Authors: Ruixue Ran, Sinan Guo, Xiaoyu Jiang, Zhanyin Qian, Zhaoyang Guo, Yinsong Wang, Mingxin Cao, Xiaoying Yang
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/1/423
Description
Summary:Radiotherapy (RT) is one of the main clinical therapeutic strategies against cancer. Currently, multiple radiosensitizers aimed at enhancing X-ray absorption in cancer tissues have been developed, while limitations still exist for their further applications, such as poor cellular uptake, hypoxia-induced radioresistance, and unavoidable damage to adjacent normal body tissues. In order to address these problems, a cell-penetrating TAT peptide (YGRKKRRQRRRC)-modified nanohybrid was constructed by doping high-Z element Au in hollow semiconductor Cu<sub>2−x</sub>Se nanoparticles for combined RT and photothermal therapy (PTT) against breast cancer. The obtained Cu<sub>2−x</sub>Se nanoparticles possessed excellent radiosensitizing properties based on their particular band structures, and high photothermal conversion efficiency beneficial for tumor ablation and promoting RT efficacy. Further doping high-Z element Au deposited more high-energy radiation for better radiosensitizing performance. Conjugation of TAT peptides outside the constructed Cu<sub>2−x</sub>Se/Au nanoparticles facilitated their cellular uptake, thus reducing overdosage-induced side effects. This prepared multifunctional nanohybrid showed powerful suppression effects towards breast cancer, both in vitro and in vivo via integrating enhanced cell penetration and uptake, and combined RT/PTT strategies.
ISSN:1420-3049